The firms hoping to take psychedelic drugs mainstream
Start-ups are tweaking psychedelic compounds to treat mental health conditions.
Source: bbc.com
Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Start-ups are tweaking psychedelic compounds to treat mental health conditions.
Start-ups are tweaking psychedelic compounds to treat mental health conditions.
Start-ups are tweaking psychedelic compounds to treat mental health conditions.
Psychedelics startups want to transform mental healthcare. But first, they need to win over the skeptics and break the taboos.
BPL-003 is Beckley Psytech's patent-protected benzoate formulation of 5-MeO-DMT (also known as Mebufotenin) and is administered intranasally via an FDA-approved delivery device. The multi-centre